Congratulations to the @UofT@UnityHealthTO@UHN@NRC_CNRC team awarded $17.5M from CFI @InnovationCA and partners to create the CRAFT Diagnostic Horizons Lab. Learn more about the Lab and its capabilities here > https://t.co/AszlE8YvYt
ThromboSeq, a cancer detection blood test using RNA isolated from tumour-educated platelets, identifies 18 different cancer types with 99% specificity (99%). 66% of known cancers in 1,096 pts, including 50% of stage I-III cancers, were correctly detected: https://t.co/6LUXsMmDuM
A blood test for #cancer: Dana-Farber's Catherine Marinac, PhD, details findings from the PATHFINDER study presented at #ESMO22. PATHFINDER examined if a simple blood test could detect a cancer signal in people ages 50 years and older who were not known to have cancer.
We are thrilled to announce the TOP 6 Finalists at the #MedTech Finals and Awards Gala! Join-us live for a great night of entertainment, networking and pitches at Baylis MedTech on April 7, 5:00pm ET.
🔗 https://t.co/oN7aNHGWAl
@steadiwear@BrazeMobility@OrangeNeuro#startups
@sonusoodtrends@dhani I hope Dhani management takes care of their existing customers. So much dissatisfaction among customers, and the above looks like a marketing gimmick.
Sonu, I truly respect what you are doing and please take care of who you back.
We are thrilled to present Enrich Bioscience's accomplishment at the TiE Toronto MedTech 2021 showcase- May 20, 2021.
Thank you, Tie-Toronto, for inviting us.
https://t.co/iK1F0j18m6
The #AIDProgram saw enthusiastic participation from #diagnostics#startups from India, Canada, USA, and South Korea!
After careful evaluation of the 76 applications by a panel of experts, we finally have the first cohort list here: https://t.co/3O7ax2KPwt
Congratulations!
Enrich Bioscience is thrilled to partner with OptraScan to connect Canadian Pathologists with Indian Pathologists for digital pathology.
https://t.co/6yeKywHgll
A most comprehensive and thoughtful discussion on
#Early Detection #Multi Cancer Single Test # Liquid Biopsy
# Treatment vs Detection.
Transforming Cancer Treatment with Early Detection Diagnostics: Opportun... https://t.co/xRnhCKB4zC via @YouTube
The first Canadian to be treated with #gene replacement therapy for a #rare form of blindness, Retinitis pigmentosa, is a beacon of hope for the thousands of #Canadians at risk of visual impairment. https://t.co/IpcZy9VcfF @HeonJeon@sickkids@SickKidsNews
Concern for the frontline workers, who had a chronic illness, and are at risk of serious illness in this uncertain time of COVID-19 pandemic.
https://t.co/fRTMy2IOtP